COMPANY PROFILE

Tongee

Explore full profile

Develops new medical technologies to treat various metabolic diseases

Hangzhou, ChinaFounded 2016Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2026

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Tongee

Tangji Medical is a healthcare company specializing in innovative treatments for metabolic diseases, including diabetes and liver conditions. The company operates in the medical and healthcare market, targeting patients suffering from chronic metabolic disorders. Tangji Medical's business model revolves around the development and commercialization of advanced medical treatments and systems, such as the gastric transfer arming system, aimed at improving patient outcomes and quality of life. Revenue is generated through the sale of these medical products and treatments, as well as through clinical trials and research collaborations. The company serves a global clientele, with a particular focus on markets with high prevalence of metabolic diseases. Tangji Medical is committed to ongoing research and development to bring cutting-edge solutions to the healthcare industry.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Hangzhou, China
Employees: 8
Open positions: None listed
Dealroom signal: 34.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Tongee.

See all news

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Jun 2026	$14M	$206M	Undisclosed	↗
SERIES COther financing	Feb 2025	$14M	$138M	Everest Venture Capital	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Tongee website traffic

Latest recorded traffic for Tongee is 570 monthly website visits, up 1325% over the last three months. Tongee's team declined 11.1% over the past year.

Latest monthly visits570 3-month web change+1325% 1-year team growth-11.1%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HTHarness TherapeuticsA private biotechnology company, headquartered in Cambridge-UK, focused on the development of a novel class of therapeutic RNAs	Babraham, United Kingdom	Operational	5	$35M	$90M
KIKimialysDeveloper of an analytical device intended to offer products based on innovative surface chemistry in the field of biosensors	Paris, France	Operational
SISideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers	Paris, France	Closed
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
BPBrenus PharmaProducing the widest panel of tumor associated antigens and resistance markers with a chemical labeling enable to induce cell death by patients' immune system	Clermont-Ferrand, France	Operational
EBExeliom BiosciencesDeveloping single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics	Dijon, France	Operational
MTModalis TherapeuticsEpigenetic gene modulation therapies for genetic disorders	Cambridge, United States	Operational
HPHcs PharmaA company specializing in cell imaging	Loos, France	Operational